Integral Ad Science Holding Corp. (NASDAQ:IAS) CEO Lisa Utzschneider Sells 5,940 Shares

Integral Ad Science Holding Corp. (NASDAQ:IAS) CEO Lisa Utzschneider sold 5,940 shares of Integral Ad Science stock in a transaction dated Tuesday, January 7th. The stock was sold at an average price of $9.75, for a total value of $57,915.00. Following the sale, the chief executive officer now directly owns 266,926 shares in the company, valued at approximately $2,602,528.50. This trade represents a 2.18 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Integral Ad Science Stock Up 4.9 %

Shares of IAS opened at $10.20 on Thursday. The business’s 50 day simple moving average is $10.97 and its 200-day simple moving average is $10.79. Integral Ad Science Holding Corp. has a one year low of $7.98 and a one year high of $17.53. The company has a market capitalization of $1.66 billion, a P/E ratio of 51.00, a PEG ratio of 1.46 and a beta of 1.46. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.71 and a quick ratio of 3.71.

Integral Ad Science (NASDAQ:IAS) last posted its quarterly earnings data on Tuesday, November 12th. The company reported $0.10 EPS for the quarter, topping analysts’ consensus estimates of $0.08 by $0.02. Integral Ad Science had a return on equity of 3.47% and a net margin of 6.39%. The company had revenue of $133.50 million for the quarter, compared to analyst estimates of $138.06 million. During the same quarter in the previous year, the firm earned ($0.09) earnings per share. The business’s revenue was up 11.0% on a year-over-year basis. As a group, sell-side analysts predict that Integral Ad Science Holding Corp. will post 0.26 EPS for the current fiscal year.

Analysts Set New Price Targets

IAS has been the topic of several recent research reports. Benchmark reissued a “hold” rating on shares of Integral Ad Science in a report on Thursday, November 14th. Piper Sandler decreased their price target on shares of Integral Ad Science from $18.00 to $16.00 and set an “overweight” rating on the stock in a research note on Wednesday, November 13th. Scotiabank assumed coverage on shares of Integral Ad Science in a research note on Thursday, December 5th. They issued a “sector perform” rating and a $10.00 price objective for the company. Oppenheimer decreased their target price on shares of Integral Ad Science from $20.00 to $18.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 13th. Finally, Craig Hallum dropped their price target on shares of Integral Ad Science from $18.00 to $16.00 and set a “buy” rating for the company in a research report on Wednesday, November 13th. Four analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $15.18.

Hedge Funds Weigh In On Integral Ad Science

A number of institutional investors have recently modified their holdings of the stock. Healthcare of Ontario Pension Plan Trust Fund acquired a new stake in shares of Integral Ad Science in the second quarter valued at approximately $4,724,000. abrdn plc boosted its position in Integral Ad Science by 12.5% in the 3rd quarter. abrdn plc now owns 2,147,656 shares of the company’s stock valued at $23,216,000 after buying an additional 237,930 shares during the last quarter. JPMorgan Chase & Co. increased its stake in shares of Integral Ad Science by 47.6% in the 3rd quarter. JPMorgan Chase & Co. now owns 717,528 shares of the company’s stock valued at $7,756,000 after buying an additional 231,271 shares during the period. Invenomic Capital Management LP lifted its stake in shares of Integral Ad Science by 57.4% during the third quarter. Invenomic Capital Management LP now owns 585,309 shares of the company’s stock valued at $6,327,000 after acquiring an additional 213,488 shares during the period. Finally, Rice Hall James & Associates LLC bought a new position in Integral Ad Science in the third quarter valued at about $1,795,000. 95.78% of the stock is owned by institutional investors.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.